Orofacial adverse effects of biological agents. - Wikidata - wikimedia - TriplyDB

Orofacial adverse effects of biological agents.

Orofacial adverse effects of biological agents.

http://www.wikidata.org/entity/Q38213692

about

Oral non-Hodgkin's lymphoma in a patient with rheumatoid arthritis treated with etanercept and methotrexate

P2860

Q35201455-533E4945-43C8-4236-9F14-46CC476980A1

P2860

Orofacial adverse effects of biological agents.

http://www.wikidata.org/entity/Q38213692

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Orofacial adverse effects of biological agents.

@en

type

label

Orofacial adverse effects of biological agents.

@en

prefLabel

Orofacial adverse effects of biological agents.

@en

P1433

Q38213692-630AF84B-092D-4647-B28B-8476F9781A37

P1476

Q38213692-F6F34FEA-58F8-4E07-80F7-D585187D7E60

P2093

Q38213692-119E7579-78DB-4D71-AEAC-3002E20128E2

Q38213692-61898509-80FA-4B31-AD2D-E88E9D9D6316

P2860

Q38213692-00FE8151-3371-4462-834C-CB71C4462A2B

Q38213692-02044A47-BF45-4FF9-BB8D-883A5090F682

Q38213692-04DFB0C9-F087-49D6-9A04-77B529482E7A

Q38213692-0A96D6BA-924F-4E6D-A54C-118EF4E204A1

Q38213692-0BC2E153-94B1-4187-9D71-E6B75065C8FC

Q38213692-0BC8AF70-65D9-4049-BFD8-0CEAC84FF4BC

Q38213692-0F7665BF-99BE-4196-9387-82202D4215E6

Q38213692-131C9EEB-1D0E-4032-98A1-B327C79648ED

Q38213692-1432D807-5A99-4FDC-80B6-019C40282069

Q38213692-17EBF091-4623-4AC6-8D80-1BF46347A28B

P304

Q38213692-E8ECD7FD-A9E0-45E6-ACB9-ED983231DD28

P31

Q38213692-64DE5B73-44AB-47A0-871E-75632D04333C

P356

Q38213692-43423988-EF59-448C-B4F5-B9E838417530

P433

Q38213692-4DF4BF09-0590-48C4-8E5E-442E2612C679

P478

Q38213692-F1A0B953-81AA-41A9-B4AD-359C5CBC2A73

P577

Q38213692-C5833B2E-0AEC-4C03-834D-768D1226E344

P698

Q38213692-1C168B6E-BD2E-4AA5-88DB-0ED24107985F

P356

P1433

Journal of investigative and clinical dentistry

P1476

Orofacial adverse effects of biological agents.

@en

P2093

Crispian Scully

http://www.w3.org/2001/XMLSchema#string

Eleni A Georgakopoulou

http://www.w3.org/2001/XMLSchema#string

P2860

Current state of renal transplant immunosuppression: Present and future

Multiple sclerosis: side effects of interferon beta therapy and their management

Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

Biologics in oral medicine: oral Crohn's disease and orofacial granulomatosis

Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment.

Use of monoclonal antibodies in renal transplantation.

P304

252-260

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JICD.12102

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24850782

http://www.w3.org/2001/XMLSchema#string